Simplifying Global Compliance
Watson Sues FDA for Failing to Grant Shared Exclusivity for Actos Generic
Washington Drug Letter
Watson Pharmaceuticals is suing the FDA after it failed to grant the company shared exclusivity on a generic of Type 2 diabetes drug Actos.
To View This Article:
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing